– About The Peptide Brief –
Peptide medicine UK, covered in plain English.
We’re the UK’s home for peptide medicine UK readers can actually trust, covering GLP-1 weight loss drugs, longevity treatments and the science behind the headlines. What’s real, what’s regulated and what’s relevant, no agenda beyond getting it right.
– Our Mission –
Why we exist.
Peptide medicine is moving fast. New GLP-1 drugs are reshaping how the UK thinks about weight loss. Longevity treatments once reserved for Silicon Valley biohackers are arriving in British clinics. The science is real, but the coverage is either too technical, too American, or too sensational.
The Peptide Brief exists to fix that. We cover what matters for a UK audience in plain English, with no agenda other than getting it right, and no payment from any clinic or manufacturer for coverage, ever.
– How We Work –
How we research peptide medicine UK news and guides.
Every guide on this site is built from primary sources first, not secondhand blog posts. That means going directly to the MHRA for licensing and safety updates, NHS England and NICE for access criteria and clinical guidance, and peer-reviewed journals such as The BMJ, The Lancet and the New England Journal of Medicine for trial data.
Where a manufacturer, clinic or regulator publishes a claim, we check it against the original document before it goes on the page, not just the press release describing it. Figures like weight loss percentages, NHS eligibility criteria and approval dates are the parts of this space that change fastest and get copied wrong most often, so they get checked most carefully.
Facts move quickly in peptide medicine UK coverage. Drug approvals, NHS criteria and pricing shift within months, sometimes weeks. When something changes, we update the page rather than leave outdated information live, and we’d rather publish a shorter, more cautious guide than a longer one padded with claims we can’t verify.
We are an independent UK editorial team. We accept no payment, free products or sponsorship from any pharmaceutical company, clinic or private provider for coverage on this site, and we say so clearly wherever a specific provider is reviewed.
If you spot something on this site that looks out of date or wrong, tell us. Start with our Weight Loss Jabs and Pills guide if you’re new to this topic, or head to Regulation and Policy for the latest on what’s changing in UK peptide medicine law and access.
01
Plain English always.
We write about complex science in plain English. No jargon, no Latin, no impenetrable studies. Just clear, honest reporting that anyone can understand and act on.
02
UK focused always.
We cover what matters for a British audience. MHRA regulations, NHS access, UK clinic options and the treatments actually available in this country, not just what works in America.
03
No hype ever.
We say what the evidence supports, what looks promising and what is speculation. We never overstate a study or underplay a risk. Trust is the only thing we have to offer.
GHK-Cu Copper Peptide
The copper peptide linked to collagen production, skin repair and cellular regeneration. We cover the research, the topical and injectable forms, and what the evidence actually supports.
NAD+ and Longevity
NMN, NR and NAD+ infusions. The cellular energy treatments gaining traction in UK clinics. We cover the science, the protocols, and whether the evidence justifies the price tag.
UK Clinic Guide
Where to get peptide treatments safely in Britain. Regulated providers, red flags to avoid, and how to tell the difference between a legitimate clinic and a grey market supplier.
Regulation and Policy
MHRA updates, NHS coverage shifts and what is changing for UK peptide access. We track the regulatory landscape so you know what is legal, what is changing, and what to watch.